Lv1
96 积分 2024-05-09 加入
High concentration formulation developability approaches and considerations
2个月前
已完结
Simultaneous Analysis of the Drug-to-Antibody Ratio, Free-Drug-Related Impurities, and Purity of Antibody–Drug Conjugates Based on Size Exclusion Chromatography
2个月前
已完结
Extending the limits of size exclusion chromatography: Simultaneous separation of free payloads and related species from antibody drug conjugates and their aggregates
2个月前
已完结
Analytical Quality by Design as applied to the development of a SEC-HPLC platform procedure for the determination of monoclonal antibody purity without mobile phase additives
2个月前
已完结
Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments
2个月前
已完结
Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments
3个月前
已完结
Modifying insulin to improve performance
4个月前
已完结
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
5个月前
已完结
Enzymatic removal of sialic acid enables iCIEF stability monitoring of charge variants of a highly sialylated bispecific antibody
5个月前
已完结
皖公网安备34019202002308
